This premier B2B event provides you with an appropriate platform to engage with and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for excellent company representation and development.
The Summit will shed light on current challenges, best practices and inside views of the future of microbiome-based products in relation to quality, safety and efficiency.
We will discuss key findings, critical insights and recommendations for driving efficient strategies within the microbiome landscape.

Meet Lutz Müller-Kuhrt in Berlin!

The international innovation and networking summit offers a platform to share ideas, cultivate high-impact partnerships and push forward new solutions to the food system’s most pressing issues.

This year, across two days of panels, fireside debates, keynote presentations and roundtable discussions, we will explore topics across alternative proteins, the intersection of health and nutrition, ingredient innovation, gut health, cellular agriculture and the future of retail.

Meet Jens-Peter Müller in London!

TPD 2019 is a dedicated scientific and networking forum for large pharma, innovative biotech and KOLs of academia to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.
As the most comprehensive and definitive event for the field of protein degradation, TPD 2019 is proud to showcase late-breaking case studies from 50+ truly world-class speakers and experts who are pioneering future trends & best practice.

Meet Dietmar Wolf in Boston!

Interfacing Chemical Biology and Drug Discovery

The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:

Targeting Proteins for the Development of New Therapeutic Strategies
Combating (Re)Emerging Pathogens
Tackling New Challenges in Drug Delivery
Exploring Biologically Relevant Molecular Space
Artificial Intelligence in Drug Discovery: Reality or Hype?
Case Studies: from Target Validation to Novel Drugs (all Therapeutic Areas included)

Meet Nadia Buonomo and Lars Ole Haustedt in Nantes!

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Meet Lutz Müller-Kuhrt in Boston!

At the Proteome- Targeted Drug Discovery Summit 2019, join 80+ senior decision makers of the field over a 3-day impactful conference, 20+ data-driven case studies, 2 workshops & 6+ dedicated hours of networking to discuss and advance identification, validation and accessing previously “undruggable” and highly desirable protein targets, whilst improving the rational design & translation of next generation small molecules.

Meet Betsy McKibben, Dietmar Wolf and Lars Ole Haustedt in Boston!

The Future Food-Tech Summit is an international networking event, bringing together food brands,entrepreneurs and investors to showcase solutions, share ideas and create new alliances.

Following 2018’s sell-out success, this year’s Future
Food-Tech Summit in New York will focus on the role of
technology in achieving healthy and sustainable food systems
in an urbanized world – exploring everything from gut-friendly
functional foods, healthier snacking and data-driven personalized
nutrition to next-generation proteins, biotech innovation and
digitized supply chains.

Meet Dietmar Wolf in NY!

The scientific programme will feature themed lectures, focusing on medicinal chemistry and related technologies and disciplines across a range of drug targets and modalities. A distinguishing feature of this symposium is the collegiate style which encourages an atmosphere of information sharing and learning.

Meet Nadia Buonomo and Lars Ole Haustedt in Snekkersten!

300 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions.

Over 60+ presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.

Meet Lars Ole Haustedt in Berlin!

Innovation in Screening Libraries by Academic Drug Discovery Consortium

This event will bring together drug-seekers from academia and industry focused on the application of new technologies and computational tools to tackle this question in order to deliver higher quality leads.

This 1.5-day meeting will create a dynamic, interactive environment for presentations and discussion, and also includes a ½-day networking session for one on one partnering meetings between participants and round table discussions on key topics Sharing libraries among academics; Informatics including data management flow; Virtual screening software tools and open source software.

Meet Betsy McKibben in Boston!

2019 represents the 30th anniversary of the Symposium on Medicinal Chemistry in Eastern England, known colloquially as the “Hatfield MedChem” meeting. This is a highly successful, long-standing, one-day annual meeting. To commemorate 30 years, the programme will focus on ‘Celebrating UK Drug Discovery’, highlighting success stories from large pharma, biotech and academia; and exciting scientific prospects for the future. Presentations will showcase medicinal chemistry from tools to candidates, across a range of modalities, therapeutic areas and target classes with an emphasis on key learnings and knowledge developed during the course of effective discovery efforts. The meeting aims to be informal and interactive and will offer excellent scientific development and networking opportunities for all those working in medicinal chemistry and drug discovery.
Meet Lars Ole Haustedt in Hatfield!

AChemS, the Association for Chemoreception Sciences, is a scientific research organization dedicated to understanding the “chemical senses” of smell, taste, trigeminal irritation and internal chemoreception from the fundamentals of neurobiology to complex behavior.

THE ACHEMS ANNUAL MEETING is the preeminent international gathering of chemoreception scientists.


Meet Dietmar Wolf in Florida!

After the huge success of our back to back conferences in Europe and U.S., we at World BI, are beyond excited for 2019 events taking place in Frankfurt, Boston, San Francisco & Barcelona.

DDIP has always proven to be a unique platform to meet senior level executives, key decision makers and experts all-around the Academic Institutions, Pharmaceutical, Biotech and lead researchers making the congress a perfect platform to share experience, foster collaborations to put forward many thought provoking strategies.

If you hope to discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world, there couldn’t be a better place for you to be on April 11-12 2019!

Meet Lars Ole Haustedt and Nadia Buonomo in Frankfurt a.M.!

Cambridge Healthtech Institute’s 14th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s personal interests by going back and forth among concurrent conferences. New for 2019 includes coverage of Artificial Intelligence for Early Drug Discovery and Directed Evolution-Based Drug Discovery, plus even more short courses to choose from.

Meet Betsy McKibben and Dietmar Wolf in San Diego!

The aim of the 7th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.

Meet Lars Ole Haustedt in Cambridge, UK!

Innovation & Investment from Farm to Fork


Future Food-Tech returns to San Francisco March 21-22, 2019.
The Summit is acclaimed as the most international gathering of food business leaders, VC investors and food-tech innovators to transform innovation and investment in food.

Meet Dietmar Wolf in San Francisco!

The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.

Meet Lars Ole Haustedt in Berlin!

This symposium will bring together scientists in biology and chemistry that rarely interact to address common questions. The interdisciplinary collaborations that result will profoundly accelerate basic microbiome research as well as help understand the role of the microbiome in human health and disease. We will emphasize speakers that employ innovative new methods and/or hypothesis-driven research to understand microbial systems at the molecular level. We have invited speakers with innovative paradigm-shifting research programs in chemistry, synthetic biology, genome editing, precision medicine, etc.

Meet Danielle Demers in Québec!

New Chemical industry customers and partners in one productive day

New customers. New partners. More turn-over. A productive day: More than 500 decision makers attended the 2nd European Chemistry Partnering. The enthusiastic participants came from large organizations as well as investors, from small and medium-sized enterprises, and above all from young companies and chemical start-ups who often find it difficult to engage with the larger companies.

Meet Jens-Peter Müller in Frankfurt a.M.!

Im Zentrum des diesjährigen 31. Symposiums stehen:

Synthese
Molekulare Interaktion
Sepsis
Chemische Ökologie

Treffen Sie Lutz Müller-Kuhrt, Lars Haustedt und Karsten Siems in Irsee!

The 4th Annual North America Microbiome Congress in Washington DC, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.
– Meet and learn from industry leaders
– Connect in person with the FDA
– Secure funding from the NIH
– Network with top academics and clinicians in the field

Meet Danielle Demers in Washington!

The 1st Annual Flavor Summit Industry Perspectives workshop, hosted by the University of Florida, Citrus Research and Education Center and the University of Florida Center for Smell and Taste. This workshop will offer insights into the cutting edge science and current industry trends relevant to flavor. Topics will include flavor generation and flavor precursors, chemosensory perception and psychophysics, consumer preferences, and natural products as sources of novel flavor compounds. The training program will be provided by leading speakers from industry, government, and academic institutions around the world. Posters and tabletop demonstrations will also be available throughout the workshop.

Meet Dietmar Wolf in Orlando!

Part of the established Microbiome Movement, the
3rd Microbiome Movement – Drug Development
Europe returns as the industry-defining forum
to help discover, develop and deliver the next
generation of microbiome-based therapeutic and
diagnostic candidates to market.
Meet Jens-Peter Müller in Paris!